Physician profile
Mark Mueller
NPI 1083607295
$696.53
in general payments reported to CMS, 2019-2025
12 companies · $533 in 2025
The $533 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $31.41 · 2024: $133 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $184.46 | 2023-2025 | Shingrix, Arexvy |
| Abbvie INC. | $84.04 | 2024-2025 | |
| Abbott Laboratories | $68.68 | 2024-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $64.01 | 2025 | Jardiance, Zepbound, Mounjaro |
| Exact Sciences Corporation | $58.94 | 2024-2025 | Cologuard Collection Kit |
| Antares Pharma, INC. | $50.60 | 2025 | Xyosted |
| Intra-Sana Laboratories | $50.00 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Astrazeneca Pharmaceuticals Lp | $41.43 | 2025 | Breztri, Airsupra |
| Pfizer INC. | $37.30 | 2025 | |
| Hologic Sales and Service, LLC | $20.22 | 2024 | Aptima |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.55 | 2025 | Jardiance |
| Baxter Healthcare | $17.30 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.